E. Randall Lanier

2.4k citations

39 papers · 1.9k indexed · h-index 24

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 28
- HIV Research and Treatment 26
Infectious Diseases 28
- HIV/AIDS drug development and treatment 22
- HIV/AIDS Research and Interventions 20

Co-authors: Marty St. Clair Daniel McClernon Justin C. McArthur Alfred J. Saah Michael F. Cronin T. E. Nance‐Sproson J. Allen McCutchan Scott Letendre
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)The Pediatric Infectious Disease Journal (4 papers)Antiviral Therapy (4 papers)Antiviral Research (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

E. Randall Lanier

39 papers receiving 1.8k citations

Peers

Countries citing papers authored by E. Randall Lanier

Since Specialization

Citations

This map shows the geographic impact of E. Randall Lanier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Randall Lanier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Randall Lanier more than expected).

Fields of papers citing papers by E. Randall Lanier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Randall Lanier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Randall Lanier. The network helps show where E. Randall Lanier may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Randall Lanier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Randall Lanier Line = papers co-authored together E. Randall Lanier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus Antiviral Research ·Laura K. McMullan, Mike Flint, Julie Dyall, César G. Albariño, Gene G. Olinger, Scott A. Foster, Phiroze Sethna, Lisa E. Hensley, Stuart T. Nichol, E. Randall Lanier, Christina F. Spiropoulou	2015	36
2	In Vitro Efficacy of Brincidofovir against Variola Virus Antimicrobial Agents and Chemotherapy ·Victoria A. Olson, Scott K. Smith, Scott A. Foster, Yu Li, E. Randall Lanier, Amr Mohieeldin, Lawrence C. Trost, Inger K. Damon	2014	47
3	Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus Antiviral Research ·Scott Parker, Sonia Mazelet, Scott A. Foster, Carmen Isabel Velásquez Monzón, Giulia Mori, E. Randall Lanier, George R. Painter, Jill Schriewer, Lawrence C. Trost, R. Mark L. Buller	2014	20
4	CMX001 (Hexadecyloxypropyl Cidofovir) Antiviral Activity against Adenovirus in Patients Correlates with Drug Levels and Viral Sensitivity Antiviral Research ·E. Randall Lanier, Wendy Painter, مرتضی مدرس غروي, Clara Fuhrer, Bernhard Lampert, Herve Momméja-Marin, Lawrence C. Trost	2011	2
5	Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001 Journal of Clinical Virology ·AM Tacon, Jane Sande, Evelio Perez‐Albuerne, Brett Loechelt, Barbara Jantausch, Wendy Painter, 栄治若築, مرتضی مدرس غروي, E. Randall Lanier, Terry J. Fry, Roberta L. DeBiasi	2010	61
6	Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir Journal of Antimicrobial Chemotherapy ·Lisa Ross, E Goldberger, Peter Gerondelis, E DeJesus, C Cohen, Joseph Horton, Marinês Lemes, E. Randall Lanier, Richard Elion, (unknown)	2009	6
7	Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy PLoS Medicine ·Jeffrey A. Johnson, LI Jin-fen, Xierong Wei, Jonathan Lipscomb, David M. Irlbeck, Charles Craig, Amanda Smith, Diane Bennett, Michael Monsour, Paul Sandstrom, E. Randall Lanier, Walid Heneine	2008	291
8	Sensitivity of Phenotypic Susceptibility Analyses for Nonthymidine Nucleoside Analogues Conferred by K65R or M184V in Mixtures with Wild-Type HIV-1 The Journal of Infectious Diseases ·Mark Underwood, Lisa Ross, David M. Irlbeck, Peter Gerondelis, E Goldberger, M H St Clair, Lan Trinh, Neil Parkin, E. Randall Lanier	2008	9
9	Differential Impact of Thymidine Analogue Mutations on Emtricitabine and Lamivudine Susceptibility JAIDS Journal of Acquired Immune Deficiency Syndromes ·Lisa Ross, Neil Parkin, Peter Gerondelis, Colombe Chappey, Mark Underwood, M H St Clair, E. Randall Lanier	2006	7
10	Diminished Selection for Thymidine-Analog Mutations Associated With the Presence of M184V in Ethiopian Children Infected With HIV Subtype C Receiving Lamivudine-Containing Therapy The Pediatric Infectious Disease Journal ·Diana Averbuch, Jonathan Schapiro, E. Randall Lanier, T. A. Tarasova, Giora Gottesman, Maryam Beheshtinasab, M. Einhorn, Galia Grisaru‐Soen, Michal Ofir, Dan Engelhard, Zehava Grossman	2006	16
11	Salvage Therapy With Abacavir and Other Reverse Transcriptase Inhibitors for Human Immunodeficiency-Associated Encephalopathy The Pediatric Infectious Disease Journal ·Jesús Saavedra‐Lozano, Ramasubramanian Krishnan, Francisco Sanz, María Luisa Navarro, Tiffany A. Campbell, E. L. Alekseev, L. D'autilia, Vishnu Namboothiri K, Cecilia Colunga-Rodríguez, Zaukiya Khamitova, L Vandegaer, David M. Irlbeck, E. Randall Lanier, Octavio Ramilo	2006	7
12	Lack of antagonism between abacavir, lamivudine, and tenofovir against wild-type and drug-resistant HIV-1. PubMed ·E. Randall Lanier, Richard Hazen, Lisa Ross, Andrew L. Freeman, Richard J. Harvey	2005	10
13	Induction With Abacavir/Lamivudine/Zidovudine Plus Efavirenz for 48 Weeks Followed by 48-Week Maintenance With Abacavir/Lamivudine/Zidovudine Alone in Antiretroviral-Naive HIV-1-Infected Patients JAIDS Journal of Acquired Immune Deficiency Syndromes ·Martin Markowitz, Christina Hill‐Zabala, T de Fatis, Edwin DeJesus, Qiming Liao, E. Randall Lanier, Elizabeth Davis, Mark S. Shaefer	2005	37
14	Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance AIDS ·Lisa Ross, Neil Parkin, Colombe Chappey, Stephen Mattingly, Marty St. Clair, Michael Bates, Margaret Tisdale, E. Randall Lanier	2004	35
15	Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral‐Naive HIV‐Infected Adults Clinical Infectious Diseases ·Edwin DeJesus, Ignacio Castro Ayala, Eugénio Teófilo, Jan Gerstoft, 徐林泉, India L Enear, Cynthia H. Brothers, Jaime E. Hernández, Asiye İnan Süer, Tab Bonny, E. Randall Lanier, Trevor R. Scott, (unknown)	2004	175
16	The Addition of Mycophenolate Mofetil to Antiretroviral Therapy Including Abacavir Is Associated With Depletion of Intracellular Deoxyguanosine Triphosphate and a Decrease in Plasma HIV-1 RNA JAIDS Journal of Acquired Immune Deficiency Syndromes ·David M. Margolis, Stephen Kewn, Jason J. Coull, Loyda Ylisastigui, Diana Turner, E. Vesik, Melanie Kaye, E. Randall Lanier, Leslie M. Shaw, David Back	2002	64
17	Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy The Journal of Pediatrics ·Cynthia McCoig, María Mercedes Castrejón, Elizabeth Castaño, Lenka Klinkovská, T Dorathy Devakirubai, Donato Di Gioia, Daniel McClernon, I. Kreslo, E. Randall Lanier, Carol Richardson, Benjamin Gillard, Seth Hetherington, Xavier Sáez‐Llorens, Octavio Ramilo	2002	43
18	The Efficacy of Potent Anti-retroviral Drug Combinations Tested in a Murine Model of HIV-1 Encephalitis Virology ·Jenae Limoges, Larisa Y. Poluektova, Winai Ratanasuwan, Jennifer Rasmussen, Marina Zelivyanskaya, Daniel McClernon, E. Randall Lanier, Howard E. Gendelman, Yuri Persidsky	2001	14
19	Cerebrospinal Fluid β Chemokine Concentrations in Neurocognitively Impaired Individuals Infected with Human Immunodeficiency Virus Type 1 The Journal of Infectious Diseases ·Scott Letendre, E. Randall Lanier, J. Allen McCutchan	1999	82
20	Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain Annals of Neurology ·Justin C. McArthur, Daniel McClernon, Michael F. Cronin, T. E. Nance‐Sproson, Alfred J. Saah, Marty St. Clair, E. Randall Lanier	1997	321

About E. Randall Lanier

E. Randall Lanier is a scholar working on Virology, Infectious Diseases, Transplantation, Epidemiology and Emergency Medicine, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (26 papers), HIV/AIDS drug development and treatment (22 papers), HIV/AIDS Research and Interventions (20 papers), Herpesvirus Infections and Treatments (8 papers), Cytomegalovirus and herpesvirus research (8 papers), Virus-based gene therapy research (3 papers), HIV-related health complications and treatments (3 papers) and Bacillus and Francisella bacterial research (2 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (1.3k citations), Emergency Medicine (263 citations), Neurology (128 citations) and Epidemiology (512 citations). E. Randall Lanier has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Marty St. Clair, Daniel McClernon, Justin C. McArthur, Alfred J. Saah, Michael F. Cronin, T. E. Nance‐Sproson, J. Allen McCutchan, Scott Letendre, David M. Irlbeck and Michael Monsour. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Agents and Chemotherapy, The Pediatric Infectious Disease Journal, Antiviral Therapy and Antiviral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact